Zhengye Biotechnology Holding Limited (ZYBT)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	211.12M
Revenue (ttm)	36.79M
Net Income (ttm)	6.35M
Shares Out	46.92M
EPS (ttm)	0.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About ZYBT

Zhengye Biotechnology Holding, through its operating entity, focus on the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. For nearly 20 years, the operating entity has been committed to enhancing the health of livestock by offering a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The operating entity’s products are available in 29 provincial regions across China and are exported overseas, to Vietnam, Pakistan, and Egypt.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2004
• Employees: 299
• Stock Exchange: NASDAQ
• Ticker Symbol: ZYBT

Financial Performance

Financial numbers in CNY